These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 11590213

  • 1. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC, Rensen PC, Dahlmans VE, van der Boom H, van Berkel TJ, Havekes LM.
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [Abstract] [Full Text] [Related]

  • 2. ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression.
    Gerritsen G, Rensen PC, Kypreos KE, Zannis VI, Havekes LM, Willems van Dijk K.
    J Lipid Res; 2005 Jul; 46(7):1466-73. PubMed ID: 15863838
    [Abstract] [Full Text] [Related]

  • 3. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
    Westerterp M, de Haan W, Berbée JF, Havekes LM, Rensen PC.
    J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL.
    J Biol Chem; 1990 Mar 15; 265(8):4266-72. PubMed ID: 2307668
    [Abstract] [Full Text] [Related]

  • 5. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL.
    Berbée JF, van der Hoogt CC, Sundararaman D, Havekes LM, Rensen PC.
    J Lipid Res; 2005 Feb 15; 46(2):297-306. PubMed ID: 15576844
    [Abstract] [Full Text] [Related]

  • 6. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
    Zsigmond E, Fuke Y, Li L, Kobayashi K, Chan L.
    J Lipid Res; 1998 Sep 15; 39(9):1852-61. PubMed ID: 9741698
    [Abstract] [Full Text] [Related]

  • 7. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ, Sawyez CG, Wolfe BM, Connelly PW, Maguire GF, Huff MW.
    J Lipid Res; 1993 May 15; 34(5):703-17. PubMed ID: 8509711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.
    Ramms B, Patel S, Nora C, Pessentheiner AR, Chang MW, Green CR, Golden GJ, Secrest P, Krauss RM, Metallo CM, Benner C, Alexander VJ, Witztum JL, Tsimikas S, Esko JD, Gordts PLSM.
    J Lipid Res; 2019 Aug 15; 60(8):1379-1395. PubMed ID: 31092690
    [Abstract] [Full Text] [Related]

  • 10. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
    Rozhkova TA, Titov VN, Amelyushkina VA, Kaba SI, Kukhartchuk VV.
    Klin Lab Diagn; 2015 Dec 15; 60(12):4-14. PubMed ID: 27032246
    [Abstract] [Full Text] [Related]

  • 11. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ, Breckenridge WC.
    Atherosclerosis; 1995 Dec 15; 118(2):193-212. PubMed ID: 8770314
    [Abstract] [Full Text] [Related]

  • 12. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
    Khetarpal SA, Zeng X, Millar JS, Vitali C, Somasundara AVH, Zanoni P, Landro JA, Barucci N, Zavadoski WJ, Sun Z, de Haard H, Toth IV, Peloso GM, Natarajan P, Cuchel M, Lund-Katz S, Phillips MC, Tall AR, Kathiresan S, DaSilva-Jardine P, Yates NA, Rader DJ.
    Nat Med; 2017 Sep 15; 23(9):1086-1094. PubMed ID: 28825717
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.
    Liu H, Labeur C, Xu CF, Ferrell R, Lins L, Brasseur R, Rosseneu M, Weiss KM, Humphries SE, Talmud PJ.
    J Lipid Res; 2000 Nov 15; 41(11):1760-71. PubMed ID: 11060345
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD, Fry GL, Bowen SL, Ruben S, Wong H, Chappell DA.
    J Lipid Res; 2000 Nov 15; 41(11):1858-71. PubMed ID: 11060356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED, Le NA, Li X, Martinson D, Brown WV.
    J Lipid Res; 1999 Oct 15; 40(10):1875-82. PubMed ID: 10508207
    [Abstract] [Full Text] [Related]

  • 17. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice.
    Qu S, Perdomo G, Su D, D'Souza FM, Shachter NS, Dong HH.
    J Lipid Res; 2007 Jul 15; 48(7):1476-87. PubMed ID: 17438339
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
    Schmitz G, Assmann G, Augustin J, Dirkes-Kersting A, Brennhaüsen B, Karoff C.
    J Lipid Res; 1985 Mar 15; 26(3):316-26. PubMed ID: 3989390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.